E64 reprogrammed the lysosome of TAMs to endow it with a suitable antigen peptide‐generating environment, thus effectively presenting tumor antigens to activate CD8+ T cells‐dependent antitumor immunity (Scheme 1B). Here, CD8A is linked to neoplasm.